Evidence map›Paper›PMID 41096662›Full record

ArticleInternational journal of molecular sciences2025

Silver(I)-NHC Complexes as Dual-Action Agents Against Pathogenic

Shaima Hkiri, Neslihan Şahin, Zübeyda Akın-Polat, Elvan Üstün, Bui Minh Thu Ly, İsmail Özdemir, David Sémeril

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Silver-Pharmaceuticals (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shaima HkiriSynthèse Organométallique et Catalyse, UMR-CNRS 7177, Strasbourg University, 67008 Strasbourg, France.
Neslihan ŞahinDepartment of Science Education, Faculty of Education, Cumhuriyet University, Sivas 58040, Türkiye.ORCID 0000-0003-1498-4170
Zübeyda Akın-PolatDepartments of Medical Parasitology, Cumhuriyet University School of Medicine, Sivas 58140, Türkiye.
Elvan ÜstünDepartment of Chemistry, Faculty of Art and Science, Ordu University, Ordu 52200, Türkiye.ORCID 0000-0002-0587-7261
Bui Minh Thu LySynthèse Organométallique et Catalyse, UMR-CNRS 7177, Strasbourg University, 67008 Strasbourg, France.
İsmail ÖzdemirDrug Application and Research Center, İnönü University, Malatya 44280, Türkiye.
David SémerilSynthèse Organométallique et Catalyse, UMR-CNRS 7177, Strasbourg University, 67008 Strasbourg, France.ORCID 0000-0002-2582-4191

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of six silver(I) complexes, namely bromo(1-benzyl-3-cinnamyl-benzimidazol-2-ylidene)silver (I) (

Indexed as

AcanthamoebaAcanthamoeba castellaniiCoordination ComplexesSilverTrophozoitesCell AdhesionHumansCoordination ComplexesSilverAcanthamoebaanti-adhesion activityanti-amoebic activityin vitro evaluationmolecular dockingN-heterocyclic carbenesilver complex

Identifiers

PMID41096662
PMCPMC12524456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.